Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
Authors:
Preprint
- 11 April 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Background. Severe COVID-19 is characterized by pro-inflammatory cytokine release syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational and clinical studies suggest famotidine, a histamine 2 receptor (H2R) antagonist widely used to treat gastroesophageal reflux disease , attenuates the clinical course of COVID-19. Because evidence is lacking for a direct antiviral activity of famotidine, a proposed mechanism of action is blocking the effects of histamine released by mast cells. Here we hypothesized that famotidine activates the inflammatory reflex, a brain-integrated vagus nerve mechanism which inhibits inflammation via alpha 7 nicotinic acetylcholine receptor ( α7nAChR ) signal transduction, to prevent cytokine storm. Methods. The potential anti-inflammatory effects of famotidine and other H2R antagonists was assessed in mice exposed to lipopolysaccharide (LPS)-induced cytokine storm. As the inflammatory reflex is integrated and can be stimulated in the brain, and H2R antagonists penetrate the blood brain barrier poorly, famotidine was administered by intracerebroventricular (ICV) or intraperitoneal (IP) routes. Results. Famotidine administered IP significantly reduced serum and splenic LPS-stimulated tumor necrosis factor α and interleukin-6 concentrations, significantly improving survival. The effects of ICV famotidine were significantly more potent as compared to the peripheral route. Mice lacking mast cells by genetic deletion also responded to famotidine, indicating the anti-inflammatory effects are not mast cell dependent. Either bilateral sub-diaphragmatic vagotomy or genetic knock-out of α7nAChR abolished the anti-inflammatory effects of famotidine, indicating the inflammatory reflex as famotidine’s mechanism of action. While the structurally similar H2R antagonist tiotidine displayed equivalent anti-inflammatory activity, the H2R antagonists cimetidine or ranitidine were ineffective even at very high dosages. Conclusions. These observations reveal a previously unidentified vagus nerve-dependent anti-inflammatory effect of famotidine in the setting of cytokine storm which is not replicated by high dosages of other H2R antagonists in clinical use. Because famotidine is more potent when administered intrathecally, these findings are also consistent with a primarily central nervous system mechanism of action.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous SystemJournal of Visualized Experiments, 2013
- TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanismImmunology Letters, 2011
- Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonistsFundamental & Clinical Pharmacology, 2011
- Mast cell‐cholinergic nerve interaction in mouse airwaysThe Journal of Physiology, 2009
- Histamine in the Nervous SystemPhysiological Reviews, 2008
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- H2‐receptor antagonists are scavengers of oxygen radicalsEuropean Journal of Clinical Investigation, 1994
- Structural characteristics of histamine H2 receptor antagonists that scavenge hypochlorous acidEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Cimetidine and other H2 receptor antagonists as powerful hydroxyl radical scavengersChemico-Biological Interactions, 1993
- Pharmacokinetic and Pharmacodynamic Properties of Histamine H2-Receptor AntagonistsClinical Pharmacokinetics, 1991